Surgery Doctors in North Bergen, NJ Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Alan Michael Stephens, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7600 River Rd, North Bergen, NJ 07047 Phone: 201-710-2753    Fax: 201-758-2470

Dr. Adriana I Suarez-ligon, MD Surgery - Surgical Oncology Medicare: Accepting Medicare Assignments Practice Location: 7650 River Rd, North Bergen, NJ 07047 Phone: 732-741-0970

Dr. Ayolola O Onayemi, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 7650 River Rd Ste 300, North Bergen, NJ 07047 Phone: 201-710-2715

Naeem Patel, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 1209 89th St, North Bergen, NJ 07047 Phone: 201-640-4415

News Archive

The resurgence of gene therapy pioneer

Twenty years ago, scientists and investors were giddy over the promise of gene therapy to cure a host of deadly diseases. But the tragic death of a young man from an experimental treatment in 1999 nearly ended a scientist's career and the entire field.

Financial results for the third quarter announced by A.D.A.M.

A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the third quarter ended September 30, 2009.

Researchers receive $1M grant to research in biological components with solid-state electronics

​An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine.

Read more Medical News

› Verified 7 days ago